Company intelligence / Profile preview

Nanostream

Pasadena, California, USA

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Nanostream was a life sciences instrumentation company specializing in microfluidic technology for high-throughput analytical chemistry. The company's primary offering was the Veloce system, a micro-parallel liquid chromatography (uPLC) platform that allowed for the simultaneous analysis of 24 samples. This technology aimed to significantly reduce the time required for drug candidate screening and process development in the pharmaceutical industry. Despite securing significant venture capital and launching commercial products, the company ceased operations in the late 2000s.

Industry: Non-Drug Biotech

Partnerships

MerckGlaxoSmithKline

Beyond the preview

Go deeper on Nanostream.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanostream.

Explore the full profile